Continue reading this on our app for a better experience

Open in App
Home Capital STI watch

STI continues upward trajectory on better results, vaccine optimism

Thiveyen Kathirrasan and Felicia Tan
Thiveyen Kathirrasan and Felicia Tan • 1 min read
STI continues upward trajectory on better results, vaccine optimism
The benchmark Straits Times Index (STI) rose 34.69 points or 1.28% as at 12.58pm to 2,746.08.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

The benchmark Straits Times Index (STI) rose 34.69 points or 1.28% as at 12.58pm to 2,746.08 on Nov 16 on hopes of a working Covid-19 vaccine, as well as on better 3Q results.

W-o-w, the STI surged 5.2% from 2,609.36 previously, continuing its upward trend since last week.

For more stories about where the money flows, click here for our Capital section

SATS Limited and Genting Singapore saw the highest gains of 25.2% and 18.1% respectively.

The CEO of SATS announced on Nov 12 that the company, which handles airline catering, airfreight and other gateway services, is also able to transport the experimental Covid-19 vaccine developed by Pfizer.


See: SATS able to transport Pfizer’s experimental Covid-19 vaccine at low temperatures: CEO

Genting Singapore, on Nov 14, reported earnings of $54.5 million for the 3QFY2020 ended Sept 30, compared to losses of $163.3 million in the 2QFY2020 ended June 30.

See also: Local gamblers drive Genting Singapore back into the black with 3Q earnings of $54.5 million

Read all the STI watch articles here.

×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.